During a week-long joint operation between U.S. Customs and Border Protection and U.S. Food and Drug Administration, CBP ...

Aug 2, 2025; El Segundo, CA, USA; Los Angeles Lakers Luka Doncic (77) is interviewed Spectrum SportsNet following a press ...

In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 ...

Eli Lilly stock beats Q2 estimates with strong sales but faces competitive risks and high valuation. Here's why investors may ...

A series of lawsuits have been filed in Marion County court alleging that drug manufacturer Eli Lilly downplayed the side ...

Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...

Katy Perry is showing off her super-slim figure in a tiny bikini on a yacht, but fans think she's gotten too skinny.

Lilly's weight-loss medications Mounjaro and Zepbound are gaining market share on Novo's Wegovy and Ozempic, but investors ...

Some studies have linked the popular weight-loss drugs with a potentially higher risk of eye problems and vision loss. Should ...

Novo Nordisk's flagship product is semaglutide. Sold under the names Ozempic and Wegovy, it's one of the leading GLP-1 ...